Table 4.

Effect of probable streptococcal infection — results for participants with a FeverPAIN scorea of ≥3 according to antibiotic strategy

Antibiotic prescribing strategyPoorer global symptomatic outcome, n (%)Interaction term (95% CI), P-valueUnivariate risk ratio (95% CI), P-valueRisk ratio controlling for baseline severity and clustering (95% CI), P-valueRisk ratio controlling for propensity score (95% CI), P-valueRisk ratio controlling for propensity score in imputed dataset (95% CI), P-value
None (reference)
n= 20
14 (70)1.001.001.001.00
Immediate
n= 281
152 (54.09)0.94 (0.84 to 1.05), P = 0.2530.78 (0.57 to 1.05), P = 0.0990.66 (0.52 to 0.84), P = 0.0010.67 (0.52 to 0.87), P = 0.0020.78 (0.58 to 1.04), P = 0.087
Delayed
n= 32
18 (56.25)0.97 (0.84 to 1.13), P = 0.7110.80 (0.53 to 1.22), P = 0.3060.79 (0.56 to 1.13), P = 0.1980.68 (0.45 to 1.04), P = 0.4930.73 (0.49 to 1.07), P = 0.108
  • a FeverPAIN score: 1 point for each of fever in the past 24 hours, purulence, rapid (within 3 days) attendance, inflamed tonsils, and no cough or cold symptoms.